DeepSeek's DeepThink R1 built a playable Pac-Man game in minutes with minimal input. We tested its reasoning, coding, and ...
Simplify database management with Chat2DB, an AI-powered tool for SQL, data analysis, and real-time dashboards. Perfect for ...
By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.